Dosing & Uses
Dosage Forms & Strengths
ophthalmic solution
- 2%
- 5%
ophthalmic ointment
- 5%
Temporary Relief of Corneal Edema
Ophthalmic solution: Instill 1-2 gtt in affected eye(s) q3-4h or as directed by physician
Ophthalmic ointment: Pull down lower lid of affected eye(s); apply a small amount (1/4 inch) of ointment to inside of eyelid; apply once daily or as directed by physician
Administration
Ophthalmic ointment recommended for nighttime use; preservative free formulation
Ophthalmic solution recommended for daytime use
Avoid contamination do not touch tip of container to any surface; replace cap after use
Dosage Forms & Strengths
opthalmic solution
- 2%
- 5%
ophthalmic ointment
- 5%
Temporary Relief of Corneal Edema
Ophthalmic solution: Instill 1-2 drops in affected eye(s) q3-4h or as directed by physician
Ophthalmic ointment: Pull down lower lid of affected eye(s); apply a small amount (1/4 inch) of ointment to inside of eyelid; apply q3-4h or as directed by physician
Administration
Ophthalmic ointment recommended for nighttime use; preservative free formulation
Ophthalmic solution recommended for daytime use
Avoid contamination do not touch tip of container to any surface; replace cap after use
Adverse Effects
Frequency Not Defined
May cause temporary burning and irritation
Warnings
Contraindications
Hypersensitivity to product or components
Cautions
For external use only
Use under supervision of physician only
Product may cause temporary burning and irritation
To avoid contamination do not touch tip of container on any surface
Keep out of reach of children; contact a poison control center right away if swallowed
Do not use if solution changes color or becomes cloudy
If condition worsens or persists for more than 72 hours or if you experience eye pain, changes in vision, continued redness or irritation of the eye consult a physician
Pregnancy & Lactation
Pregnant or breastfeeding patients should seek advice of health care provider before using OTC drugs
Lactation: Consult a health care provider before using in breast-feeding women.
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Reduces corneal edema and associated symptoms by osmotic pressure control; draws excess fluid from cornea into tears
